Sleep Disorders Trial, Recruiting NCT06155916 Sponsor: Helsinki University Central Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06155916
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had painful nerve damage (a condition affecting the nerves outside the brain and spinal cord) that has lasted for more than 3 months
  • Your pain has been moderate to severe, meaning you would rate it at least 4 out of 10 on a pain scale over the past week

Who may not be able to join:

  • You have been diagnosed with psychotic depression or a significant form of bipolar disorder
  • You have something in or on your body that would make it unsafe to have a brain MRI scan, such as certain metal implants or devices (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hanna Harno, PhD, Helsinki University Hospital, Department of Neurology

Phone: +358503427375

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Helsinki University Central Hospital
Registry
ClinicalTrials.gov
Start date
22 November 2022
Est. completion
1 December 2025

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Pregabalin response to pain; Pregabalin effect on sleep stages; Sleep disturbance associations to brain network connectivity; Sleep disturbance associations to choroid plexus volume in brain fMRI; Pregabalin effect on circadian rhythms; Pregabalin effect on body temperature during sleep

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov